Know What's Happening in BioTech
Know What's Happening in BioTech
BioTech Pulse
EMAIL DIGESTS
Daily
Every morning
Weekly
Tuesday recap
EMAIL DIGESTS
Daily
Every morning
Weekly
Tuesday recap
ROSS introduced the CDA‑200 Dual Shaft Mixer, engineered for high‑viscosity pharmaceutical batches up to 500,000 cP and 200 gallons per run. The system pairs a 10‑hp anchor agitator with a high‑speed disperser, creating a vortex that rapidly wets dry ingredients and ensures uniform dispersion. Contamination risks are reduced by eliminating submerged bearings, while Teflon scrapers and stainless‑steel jackets provide precise thermal control. Integrated vacuum up to 29.5 in Hg and safety interlocks enhance product quality and regulatory compliance.
Researchers at TU Wien have created a hybrid microscopy technique that merges single‑molecule localization microscopy with atomic force microscopy to directly measure the refractive index of biological samples at nanometer scales. By using AFM‑derived topography to decouple distance‑related blur from...
In this 36‑minute episode, host Riley Elmer breaks down five essential principles for effective scientific mentorship, emphasizing the importance of aligning values, seeking mentors beyond just technical expertise, and using productive tension to foster growth. He shares personal anecdotes that...
A recent BMC Nursing study compared nursing‑led tele‑coaching with traditional in‑person nursing for women with gestational diabetes. Participants receiving tele‑coaching reported higher self‑efficacy, better adherence to diet and exercise, and improved glucose control. The intervention leveraged regular video consults, personalized...
A recent study demonstrates that transferring fecal microbiota from young to old mice restores intestinal stem cell (ISC) function by reactivating canonical Wnt signaling. The young‑derived microbiota increased expression of Ascl2 and Lgr5, boosted crypt mitotic activity, and improved regenerative...
Ruxolitinib, a JAK1/2 inhibitor, is being evaluated as a second‑line therapy for bronchiolitis obliterans (BO) in patients who fail conventional steroids. A recent multicenter Phase II trial involving 48 post‑transplant recipients reported a 45% median improvement in forced expiratory volume...
My colleague @adamfeuerstein is reporting today that @DrPatrick "mischaracterized the outcome of a face-to-face meeting he had with FDA officials" to broaden the use of Anktiva, the bladder cancer drug that is sold by ImmunityBio, where Soon-Shiong is chairman. Adam reports...
Takeda’s incoming CEO Julie Kim said the company anticipated Medicare’s selection of Entyvio for upcoming coverage negotiations. Entyvio, Takeda’s top-selling inflammatory‑bowel‑disease biologic, generated roughly $2.5 billion in 2023 revenue. While the firm expects a constructive dialogue, it has not disclosed pricing...
A recent review in Advanced NanoBiomed Research maps how graphene and its derivatives could be deployed at multiple points in the malaria fight. It details synthesis routes—from mechanical exfoliation to green chemistry— and highlights three intervention zones: physical barriers on...
A recent study demonstrates that electrographic cue reactivity measured in the nucleus accumbens aligns closely with clinical outcomes of deep brain stimulation (DBS) for addiction and mood disorders. Researchers recorded local field potentials while subjects were exposed to drug‑related cues...
Researchers led by Lim, Choi, and Han have introduced a scalable in‑situ fabrication method for multimodal electronic skin that integrates pressure, temperature, and strain sensors directly onto robotic surfaces. The process combines deposition and patterning in a single workflow, using...
Takeda’s incoming chief executive publicly stated that the company is not supportive of President Donald Trump’s proposed “most favored nation” (MFN) agreements with pharmaceutical manufacturers. The MFN framework would grant U.S. drugmakers preferential pricing and market‑access terms, a move Takeda...
A stretchable MXene‑based hydrogel sensor has been demonstrated to monitor heart rate and respiration continuously during intense endurance exercise. The dual‑network polymer retains over 94 % of its water content after six hours at 38 °C, stretches up to 800 % strain, and...
Researchers at INL unveiled a CMOS platform that simultaneously reads 32 graphene field‑effect transistor sensors at 16 kS/s per channel, enabling real‑time, high‑resolution mapping of neurochemical signals. The integrated chip converts minute ionic currents into digital data while maintaining low power...
In 2025 the FDA approved fifteen novel large‑molecule therapies, representing 33 % of all new drug approvals that year. The slate was dominated by oncology biologics, including five antibody‑drug conjugates and bispecific antibodies, while non‑cancer indications saw first‑in‑class agents for hereditary...
A recent study examined the anthocyanin profiles of multiple strawberry cultivars and linked higher pigment concentrations to measurable anti‑inflammatory effects in vitro and in animal models. Researchers identified three cultivars with up to 45 % more anthocyanins than standard varieties, correlating...
The House Judiciary Committee released a report alleging that CVS Health engaged in antitrust practices to suppress disruptive pharmacy startups. The findings highlight potential collusion with insurers and pharmacy benefit managers to limit market entry. Industry observers note that the...
Researchers introduced a two‑stage inertial microfluidic platform that enriches activated T‑cells without magnetic beads. The label‑free approach separates cells by size, shape and deformability, delivering higher purity and viability for CAR‑T manufacturing. Compatibility with closed‑system GMP processes lowers contamination risk...
Researchers have created an edible nanoclay‑melon protein coating that dramatically prolongs the shelf life of fresh mushrooms. Laboratory tests showed the coating extended freshness by up to seven days and cut weight loss by roughly 40% compared with untreated produce....
Sanofi announced a broad portfolio review that will cut several late‑stage drug programs, aiming to streamline its pipeline and improve cost efficiency. The cull affects multiple candidates across therapeutic areas, though specific names were not disclosed. In parallel, Breakthru Medicine...
Breakthru Medicine, a Phoenix‑based oncology startup, announced a $60 million Series A round led by a board of seasoned investors including Dave Morehead, Fred Eshelman and Mark Gergen. The capital will fund expansion of its precision‑therapy platform targeting solid tumors deemed “undruggable.” Breakthru’s pipeline...
Summit Therapeutics announced that the U.S. Food and Drug Administration has set a target date of November 2024 to render a decision on its flagship cancer immunotherapy. The drug, positioned as a next‑generation immuno‑oncology agent, has completed its pivotal Phase III...
Biotech is emerging from a multi‑year slump into a new cycle driven by late‑stage, asset‑centric deals, as highlighted at JPM 2026. While headline megadeals were scarce, rumors around Revolution Medicines and Abivax and announced transactions such as Eli Lilly‑Ventyx and GSK‑RAPT underscored...
A Tanzanian cohort study found that 30% of patients with type 2 diabetes exhibit metabolic dysfunction‑associated steatotic liver disease (MASLD). Obesity, high‑calorie diets and physical inactivity emerged as the strongest predictors, while hypertension and dyslipidemia frequently co‑occurred. The research highlights a...
A recent multicenter study proposes the platelet‑to‑neutrophil ratio (PNR) as a novel biomarker for managing sickle cell disease. Researchers found that patients with elevated PNR experienced more frequent vaso‑occlusive crises and higher hospitalization rates. The ratio, derived from a routine...
Iran’s obesity prevalence has risen to about 25%, driving a sharp increase in treatment demand and costs. Direct medical spending on obesity now exceeds 1% of the national health budget, with bariatric surgery accounting for nearly half of that outlay....
AstraZeneca announced a $15 billion investment in its China operations through 2030, aimed at bolstering capabilities in cell therapies and radioconjugates. The funding will support the full drug development chain, from design to manufacturing, and expand existing production sites in Wuxi,...
Sanofi reported a 2.5% decline in 2025 vaccine revenue to €2 bn, marking a continued sales dip amid rising U.S. vaccine skepticism. The drop was offset by a 31.5% surge in flu and COVID‑19 vaccine sales, driven by higher virus circulation...
BioMed X, a German pharma innovation hub, has teamed up with the Barbados government and the EU’s PharmaNext programme to launch an AI‑enabled research initiative targeting early diabetic kidney disease in the island’s type‑2 diabetes population. The project will combine...
A recent study employing network analysis links mobile phone usage patterns to sleep disturbance. The research finds that high-frequency nighttime screen time, especially blue‑light exposure, is the strongest predictor of reduced sleep duration and poorer sleep quality. Young adults and...
Roche’s oral breast‑cancer therapy is gaining momentum after two positive late‑stage trial readouts demonstrated strong efficacy and tolerable safety. The company has submitted a U.S. FDA filing and expects a decision later this year. An additional pivotal trial will report...
Formation Bio announced a licensing agreement to acquire rights to a miR‑124‑based drug candidate from a Chinese partner, mirroring the target of French biotech Abivax’s recently successful ulcerative colitis therapy. The deal positions Formation Bio to enter the rapidly expanding...
Researchers at the University of Macau introduced a digital microfluidic chip fabricated in a single 3D‑printing step that incorporates micro‑structured wells directly onto the electrodes. The device precisely moves droplets, captures cells, and rapidly forms viable 3D spheroids that persist...
Sanofi announced a €14‑15 billion budget for mergers and acquisitions in 2026, alongside a bolstered R&D spend of roughly €7 billion. The pharmaceutical giant aims to counter the looming revenue gap from Dupixent’s patent expiration expected around 2027. Management expects the combined...
Eli Lilly has signed a strategic alliance with Repertoire Immune Medicines, providing $85 million upfront and up to $1.84 billion in milestone payments to develop T‑cell‑targeted therapies for autoimmune diseases. The collaboration will use Repertoire’s DECODE platform to pinpoint T‑cell antigen interactions, aiming...
Researchers demonstrated that regular exercise markedly reduces the gut‑derived inflammatory metabolite trimethylamine N‑oxide (TMAO) in an aging rat model, lowering plasma TMAO by roughly 40%. The reduction coincided with significant improvements in cognitive performance, with the discrimination index rising 22.6%...
Biopharma sentiment just snapped higher $XBI BPSI index jumped 78 to 90 in Q1. That is not a grind. That is a turn. Under the hood: >Current Conditions surged 58 to 75. Pain is easing now, not someday. >12-month Expectations hit 100 for the first...
Not true. LLMs can run experiments with access to an autonomous lab and this is where they'll make scientific breakthroughs in the near term. Running experiments is about logical experimental planning (controls, replicates, etc), data analysis, and cycling on that. ...
Researchers have engineered artificial cell microspheres (Fmito@ACs) that encapsulate healthy mitochondria from fetal mouse mesenchymal stem cells, shielding them from degradation in circulation. By applying an external magnetic field, these microspheres can be directed to bone fracture sites, where they...
This Teen Never Got His Day in Vaccine Court. His Former Lawyer Now Advises RFK on Its Overhaul. This story complicates the simple. https://t.co/RSrad8WOnh
With a tipoff from a friend, and some info that probably shouldn't have been posted in a trial registry, the mechanisms of ADCs JNJ-95437446 $JNJ & SKB571/ MK-2750 $MRK have been revealed. Quite amazing given the recent $GMAB news. Via...
ENA Respiratory has initiated dosing in a Phase 2 clinical trial of its intranasal antiviral, INNA‑051. The study evaluates the spray’s ability to curb viral replication in the upper respiratory tract of adults presenting mild respiratory symptoms. Approximately 200 participants will...
Looks like $SNY discontinued Alphamedix/ SAR447873, licensed in Sep 2024 from Radiomedix & Orano Med, h/t B Riley. @ByMadeleineA covered it at #Esmo25 and flagged dysphagia & renal tox. https://t.co/6L2O0c5cOA Good news for $CATX?
#CDC sets the list of vaccinations recommended for all kids. But decisions about which inoculations kids require for school entry are made at the state level. Anti-vax forces are shifting their focus there @danielpayne.bsky.social & @isabellacueto.bsky.social report. https://t.co/9VPajcWzdI
The FDA has placed Otsuka Pharma’s centanafidine under priority review, with a decision expected by July 24. The drug is the first norepinephrine‑dopamine‑serotonin reuptake inhibitor (NDSRI) aimed at children, adolescents, and adults with ADHD, and is backed by four phase 3 trials...
People who oppose #vaccines often claim that doctors push them because they're paid to by Pharma or that vaccine administration is a big revenue source for doctors. The reality: Delivering vaccine puts an economic strain on many pediatric practices. https://t.co/cyJj1M2SPB
Bioinformatics is more about biology and code. It's shells and sessions, exports and environments. Ever been confused by “login shell” vs “interactive shell”? This thread is for you. 🧵 https://t.co/DfB8BEztiD
A multi‑center analysis published this week links TP53 mutations to markedly poorer outcomes in diffuse large B‑cell lymphoma (DLBCL). The study, encompassing 1,200 patients treated with R‑CHOP, found TP53 alterations in roughly 20% of cases and associated them with a...
A University of Bonn randomized trial found that a two‑day, calorie‑restricted oatmeal diet lowered LDL cholesterol by about 10% in participants with metabolic syndrome. The intensive oat regimen also produced an average two‑kilogram weight loss and modest blood‑pressure reductions. Gut‑microbiome...
A recent industry study reveals that hearing‑aid abandonment rates have fallen to 15% in the U.S., down from 30% a decade ago, driven by improved device comfort, AI‑powered personalization, and direct‑to‑consumer sales channels. The research highlights that younger adults (35‑54)...
